Bristol-Myers Squibb Company
Sulfone pyridine alkyl amide-substituted heteroaryl compounds
Last updated:
Abstract:
Compounds having the following formula I: ##STR00001## or a stereoisomer or pharmaceutically-acceptable salt thereof, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFN.alpha., by acting on Tyk-2 to cause signal transduction inhibition.
Status:
Grant
Type:
Utility
Filling date:
20 Nov 2018
Issue date:
1 Jun 2021